Changing the future of Oncology.


Open Letter From Our CEO

Today, I want to clearly state, that America still has a very long way to go to fulfill the hard won promises of the Civil Rights era of the 60s. I was born in 1957 and so was first exposed to civil rights issues as a child. But I was from an aspiring middle class...

read more

Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity

Additionally, Sutro’s partner Merck KGaA, Darmstadt, Germany, will be unveiling preclinical data from the collaboration’s pre-Development Candidate, a first-in-class bispecific antibody-drug conjugate targeting EGFR and MUC1 SOUTH SAN FRANCISCO, Calif., June 22, 2020...

read more